IRVINE, Calif., Feb. 19, 2025 /PRNewswire/ -- Bright Uro, a medical device company with a mission to transform care for lower urinary tract symptoms (LUTS) through innovations in urodynamics ...

The global Benign Prostatic Hyperplasia Surgical Treatment market, valued at US$11.92 billion in 2023, is forecasted to grow ...

EMJ is pleased to welcome Marcus Drake, Professor of Neurological Urology at Imperial College London, UK, who shared insights ...

A recent case report linked kidney injury to a poorly placed menstrual cup. Experts offered tips for guiding patients on ...

Lower urinary tract symptoms associated to benign prostatic hyperplasia (LUTS/BPH) is a growing condition in males associated to a high clinical, economic and humanistic burden. Currently, there is a ...

HIV symptoms vary by the stage of infection, known as acute HIV infection (Stage 1), chronic HIV infection (Stage 2), and AIDS (Stage 3). During primary infection, the symptoms are caused by the virus ...

根据住友制药美国公司 (SMPA) 发布的新闻稿，FDA 批准 vibegron (Gemtesa；住友制药美国公司)，这是一种每日服用一次的 β-3 (β 3 ) 肾上腺素能受体激动剂，用于治疗患有膀胱过度活动症 (OAB) ...

The treatment of benign prostatic hyperplasia (BPH) that causes lower urinary tract symptoms has advanced enormously since the days when it was a simple choice between no treatment with ...

Colon cancer develops when tumorous growths form in the large intestine. It often produces no symptoms in the early stages, but people should see a doctor if they notice persistent changes in ...